☆ 4.5 Article

MBD4-associated neoplasia syndrome: screening of cases with suggestive phenotypes

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Genetics & Heredity

Germline MBD4 deficiency causes a multi-tumor predisposition syndrome

Claire Palles et al.

Summary: We report a autosomal recessive multi-organ tumor predisposition syndrome caused by bi-allelic loss-of-function germline variants in the BER gene MBD4. The syndrome includes adenomatous colorectal polyposis, acute myeloid leukemia, and uveal melanoma. The colorectal adenomas from MBD4-deficient individuals showed a mutator phenotype attributable to mutational signature SBS1.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

添加到收藏夹

Letter Hematology

Methyl-CpG binding domain 4, DNA glycosylase (MBD4)-associated neoplasia syndrome associated with a homozygous missense variant in MBD4: Expansion of an emerging phenotype

Piers Blombery et al.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Substitution mutational signatures in whole-genome-sequenced cancers in the UK population

Andrea Degasperi et al.

Summary: Whole-genome sequencing allows for comprehensive analysis of cancer genomes, revealing mutational signatures and DNA repair processes. This study analyzed 12,222 tumor-normal matched samples using mutational signature analysis. The results showed that tumors in each organ have a limited number of common signatures and a long tail of rare signatures, providing a practical solution for future analyses.

SCIENCE (2022)

添加到收藏夹

Review Oncology

Imaging of Uveal Melanoma-Current Standard and Methods in Development

Malgorzata Solnik et al.

Summary: Uveal melanoma is a common intraocular tumor derived from melanocytes. The liver is the most common site of metastases. Different imaging techniques, such as fundus imaging, ultrasonography, optical coherence tomography, and others, are used for diagnostics, but their precision and quality are sometimes imperfect. This review discusses currently used imaging modalities and introduces experimental techniques for future clinical practice. It also highlights the potential of personalized medicine in uveal melanoma treatment.

CANCERS (2022)

添加到收藏夹

Article Oncology

MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients

Mathilde Saint-Ghislain et al.

Summary: In patients with metastatic uveal melanomas, MBD4 mutations are associated with response to immune checkpoint inhibitors, progression-free survival, and overall survival benefits. MBD4 could serve as a predictive biomarker for the efficacy of ICI treatment.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Genetics & Heredity

Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria

Vikas Pejaver et al.

Summary: The American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) provide recommendations for interpreting sequence variants, specifying the use of computational predictors as evidence for pathogenicity or benignity. However, the lack of quantitative support in the score intervals defined by tool developers and ACMG/AMP recommendations that require consensus of multiple predictors is addressed by a probabilistic framework proposed by the researchers. This framework is extended to computational predictors and introduces a new standard for converting tool scores to evidence strengths.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

添加到收藏夹

Article Oncology

Germline MBD4 Mutations and Predisposition to Uveal Melanoma

Anne-Celine Derrien et al.

Summary: The study identified MBD4 as a new predisposing gene for UM associated with high mutation M3 tumors, leading to increased incidence and high tumor mutation burden in UM. Tumors carrying MBD4 mutations may respond to immunotherapy.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

添加到收藏夹

Meeting Abstract Hematology

Germline Biallelic Loss in MBD4 leading to Early Onset AML with Hyper-Mutator Genomic Signature

Brittany L. Griffin et al.

BLOOD (2021)

添加到收藏夹

Article Oncology

A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies

Andrea Degasperi et al.

NATURE CANCER (2020)

添加到收藏夹

Article Genetics & Heredity

Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab

Peter A. Johansson et al.

IMMUNOGENETICS (2019)

添加到收藏夹

Review Oncology

NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?

Robbert D. A. Weren et al.

JOURNAL OF PATHOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors

Manuel Rodrigues et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Article Hematology

MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML

Mathijs A. Sanders et al.

BLOOD (2018)

添加到收藏夹

Article Genetics & Heredity

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Sue Richards et al.

GENETICS IN MEDICINE (2015)

添加到收藏夹

Article Oncology

Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis

Rossella Tricarico et al.

ONCOTARGET (2015)

添加到收藏夹

Review Biotechnology & Applied Microbiology

MBD4 and TDG: Multifaceted DNA glycosylases with ever expanding biological roles

Ashley B. Sjolund et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2013)

添加到收藏夹

Article Cell Biology

Base Excision Repair

Hans E. Krokan et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.